RecruitingNCT06612541

Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity


Sponsor

Vanderbilt University Medical Center

Enrollment

90 participants

Start Date

Feb 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.


Eligibility

Min Age: 24 WeeksMax Age: 34 Weeks

Inclusion Criteria1

  • Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth

Exclusion Criteria2

  • Infants surgically treated for ROP
  • Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06612541


Related Trials